Politico June 16, 2023
The agency followed the guidance of its independent advisory committee, which identified a commonly circulating strain of the SARS-CoV-2 virus.
The FDA on Friday selected a specific Covid strain to be used in the next booster that should be ready for the public sometime in September.
The agency directed vaccine manufacturers that have authorized or approved Covid boosters to begin gearing up manufacturing of the selected strain, which accounts for about 40 percent of infections in the U.S. currently. The FDA also wants vaccine makers to continue testing the updated booster in trials to demonstrate that it will likely offer protection against severe disease and hospitalizations.
Today's Sponsors
Today's Sponsor